MegaRobo Raises Nearly $200M to Expand AI for Science Globally

What happened
On November 19, 2026, MegaRobo Technologies announced it had raised nearly $200 million in new funding. The investment will be used to expand its AI-driven scientific discovery platform internationally and to build infrastructure connecting AI with laboratory instruments and robotics. The funding round included new investors Oman Investment Authority and CMB International, alongside existing backers. MegaRobo aims to automate scientific experiments and accelerate research by integrating AI with physical laboratory systems.
Key details
- MegaRobo has now raised about $600 million in total funding across several rounds.
- The company's Megalaxy Lab platform has served over 200 customers.
- MegaRobo's products and technologies are used by more than 500 organizations, including pharmaceutical and biotech firms.
- The Poreva Open initiative will validate over 10,000 protein-design sequences in laboratory experiments.
- MegaRobo plans to expand operations in North America, Europe, the Middle East, and Asia.
Why it matters
Pharmaceutical companies, biotechnology firms, and research institutions using MegaRobo's platforms will gain access to more automated and scalable experimental capabilities. The new funding allows MegaRobo to offer its AI-integrated laboratory infrastructure to a wider range of global customers, potentially reducing the time and cost required for scientific discovery. Scientists and AI developers can now use programmable laboratory resources on demand, making it easier to run and validate experiments at scale.
